BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Venugopal V, Sumi S. Molecular Biomarkers and Drug Targets in Brain Arteriovenous and Cavernous Malformations: Where Are We? Stroke 2021;:STROKEAHA121035654. [PMID: 34784742 DOI: 10.1161/STROKEAHA.121.035654] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Hongo H, Miyawaki S, Teranishi Y, Ishigami D, Ohara K, Sakai Y, Shimada D, Umekawa M, Koizumi S, Ono H, Nakatomi H, Saito N. Genetics of brain arteriovenous malformations and cerebral cavernous malformations. J Hum Genet 2022. [PMID: 35831630 DOI: 10.1038/s10038-022-01063-8] [Reference Citation Analysis]
2 Tu T, Peng Z, Ren J, Zhang H. Cerebral Cavernous Malformation: Immune and Inflammatory Perspectives. Front Immunol 2022;13:922281. [DOI: 10.3389/fimmu.2022.922281] [Reference Citation Analysis]
3 Tauziède-Espariat A, Pierre T, Wassef M, Castel D, Riant F, Grill J, Roux A, Pallud J, Dezamis E, Bresson D, Benichi S, Blauwblomme T, Benzohra D, Gauchotte G, Pouget C, Colnat-Coulbois S, Mokhtari K, Balleyguier C, Larousserie F, Dangouloff-Ros V, Boddaert N, Debily MA, Hasty L, Polivka M, Adle-Biassette H, Métais A, Lechapt E, Chrétien F, Sahm F, Sievers P, Varlet P; RENOCLIP-LOC. The dural angioleiomyoma harbors frequent GJA4 mutation and a distinct DNA methylation profile. Acta Neuropathol Commun 2022;10:81. [PMID: 35642047 DOI: 10.1186/s40478-022-01384-x] [Reference Citation Analysis]
4 Phillips CM, Stamatovic SM, Keep RF, Andjelkovic AV. Cerebral Cavernous Malformation Pathogenesis: Investigating Lesion Formation and Progression with Animal Models. IJMS 2022;23:5000. [DOI: 10.3390/ijms23095000] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]